Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does every drug eventually get a code ?
That’s true it’s tough having a drug that has the potential to work on multiple diseases
That was his opinion end of November I wonder what he would say now with all the great news we have received since than . Things could go ballistic soon
Inch by inch we move forward shorts better cover unless they like losing money
Nice finish!
That’s the object you make money so you can stay in business CYDY doesn’t get free money from the FDA only sub par Big pharmaceuticals drugs do
Good article published yesterday in STAT news written by Elizabeth Cooney about long haulers . Hope that CYDY trials on long haulers can help the millions of people thru out the world
Shouldn’t make difference since 100,000 doses would only cover about 1/1000 of 1 percent of world’s population we need multiple therapy companies that treat this pandemic
Are most vaccines and therapy drugs assigned a code or do they apply for the code
There is no sides meaning HGEN against CYDY . It’s vaccines and therapy drugs against the COVID-19 period. Two things 1# even if both where approved they wouldn’t be able to help the world’s population fast enough and 2# on investing you should never have all your apples in one basket. Happy holidays to all and here’s hoping HGEN and the other gets approved
We have a suburb Buffalo that put up Christmas lights like the griswalds on Christmas vacation. Driving into that community is like getting into a concert there taking collections for front liners . There are collection boxes everywhere lots of people contributing it’s awesome Thank you front liners and happy holidays to everybody
I’m hoping for both we need them now .
It was 195 patients and I believe only trial that was given Green light to continue without changes. The FDA liked what they saw GLTU
No there were no long haulers a year ago it’s just another step of all the positives leronlimab will have on covid and other diseases such as HIV - Cancer - Nash
Tune in and find out
Unexpectedly got more bang for my buck maybe I can get back to 2019 share count.
I wouldn’t think the FDA would let the eIND go forward if it wasn’t good in the 1st 60 patients months ago they have all the results plus have probably seen the results at 50% on C-12 trial. I’d say where good here
Remember longs he who laughs last laughs longest
Back when it went up to $10 there was a lot of excitement hype definitely pushed it up what’s happening now is a slow climb with a lot more of the past catalysts and new catalysts coming closer to end points. Imo it was never about weather we had a good drug it was finishing the trials we have a CD-12 trial fully enrolled and are the only one at 50% the was told to continue on with no changes for end points that’s huge and as of today we have a EIND that the FDA has allowed again that’s great news
Lol I think I’ll get a happy meal
And 1000’s are down so I’ll take the15%
Your posts are great thanks for reply
Thanks
Is there a % over standard of care in order to be considered we would have to meet?
Some not all there’s more CYDY investors here than you know. Plus the fact that both together probably wouldn’t be able to provide enough drug for the world here’s hoping for both
So having a average of less than a dollar last year in CYDY and riding free shares after making 600% there and seeing potential with HGEN makes us a idiot probably not a good idea to assume doesn’t bode well for that statement GLTU
King of the hill
Both are great buys
Great news contracts until 2022 not bad
At some point all the people hoping for cheaper shares are going to realize this might be the time to buy or pay more later
They where on Ecmo weren’t they ? I haven’t seen any trials anywhere besides that one with patients like that. But I may be wrong
Completed 390 enrollment in COVID-19 phase 3 C-12 trial and where only company that had trial at 50% that got green light to carry on WITHOUT changing end points.
When I bought in I expected things happening faster but than covid hit and had to change timeline to next year no big deal I’m patient and will hold because the potential here is big. GLTA
Getting close this has been one of my easiest stocks to hold small float and no constant pumping like others GLTA
Yeah ! Above my average again GLTA
Should have been here last year when shares where under a dollar most longs probably sold and banked 6 figures and are riding free shares ooh we’ll win some loss some such is the OTC where timing sometimes is everything. If you buy in now you can take the ride and make some money GLTU
More like bags of money come 2021
Should be a great new year with everything CYDY has in the works
Happy Friday everyone let’s hope we get into a upward trend and finish year off on a high note
The CC was exactly what CYDY said a UPDATE not a game changer like some hope. Things are moving forward not backwards GLTA